Published March 2, 2026 | Version v1

THE SALIVARY BLUEPRINT OF ORAL CANCER: FROM MOLECULAR CLUES TO CLINICAL APPLICATION

  • 1. Government Dental College Kottayam, Kerala, India.

Description

Oral squamous cell carcinoma (OSCC), which is the most prevalent malignancy in the oral cavity, poses a significant health challenge globally due to its high rates of mortality and morbidity. Despite considerable progress in both diagnostic and treatment methods, the survival rates for patients with OSCC have not seen significant improvement over the years. Recent developments in multi-omics technologies have enabled a deeper exploration of salivary components, including DNA, RNA, proteins, metabolites, and extracellular vesicles, which can provide insights into localized tumor behaviour and broader physiological changes in the body. This review summarizes the current evidence related to various types of salivary biomarkers in OSCC, including proteomic, transcriptomic, genomic, epigenetic, metabolomic, and microbial markers. Furthermore, it addresses the clinical implications, challenges, and future potential of saliva-based diagnostics, emphasizing how saliva omics could transform the early detection and continuous monitoring of OSCC.

Files

The Salivary Blueprint of Oral Cancer- from Molecular Clues to Clinical Application.pdf

Files (462.2 kB)

Additional details

References

  • 1. Bugshan, A.; Farooq, I. Oral squamous cell carcinoma: Metastasis, potentially associated malignant disorders, etiology and recent advancements in diagnosis. F1000Research, 2020; 9: 229.
  • 2. Gigliotti, J.; Madathil, S.; Makhoul, N. Delays in oral cavity cancer. Int. J. Oral Maxillofac. Surg, 2019; 48: 1131–1137.
  • 3. Rivera C, Oliveira AK, Costa RAP, De Rossi T, Paes Leme AF. Prognostic biomarkers in oral squamous cell car¬cinoma: A systematic review. Oral Oncol, 2017; 72: 38-47.
  • 4. Chundru VN, Nirmal RM, Srikanth B, Bojji M, Midhun N, Lakshmi BJ. Salivaomics for oral cancer detection: An insight. Journal of Pharmacy & Bioallied Sciences, 2021 Jun; 13(Suppl 1): S52.
  • 5. Khurshid Z, Zafar MS, Khan RS, Najeeb S, Slowey PD, Rehman IU. Role of salivary biomarkers in oral cancer detection. Advances in clinical chemistry, 2018 Jan 1; 86: 237.
  • 6. Sannam Khan R, Khurshid Z, Akhbar S, Faraz Moin S. Advances of Salivary Proteomics in Oral Squamous Cell Carcinoma (OSCC) Detection: An Update. Proteomes, 2016; 4(4): E41.
  • 7. Pepe MS, Etzioni R, Feng Z, Potter JD, Thompson ML, Thornquist M, et al Phases of Biomarker Development for Early Detection of Cancer. J Natl Cancer Inst, 2001; 93(14): 1054-61.
  • 8. Bitonti V, Gravili G, Berveglieri C, Familiari D, Cigni L, Franco R. Salivary Proteomics and Its Role in the Early Detection of Oral Cancer: A New Frontier in Noninvasive Diagnostics. The Open Medicine Journal, 2025 Nov 26; 12(1).
  • 9. Ferrari E, Pezzi ME, Cassi D, Pertinhez TA, Spisni A, Meleti M. Salivary cytokines as biomarkers for oral squamous cell carcinoma: a systematic review. International journal of molecular sciences, 2021 Jun 24; 22(13): 6795.
  • 10. Fang J, Shing Y, Wiederschain D, Yan L, ButterWeld C, Jackson G, Harper J, Tamvakopoulos G, Moses MA, Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model. Proc Natl Acad Sci USA, 2000; 97(8): 3884–3889.
  • 11. De Jong EP, Xie H, Onsongo G, Stone MD, Chen XB, Kooren JA, Refsland EW, Griffin RJ, Ondrey FG, Wu B, Le CT. Quantitative proteomics reveals myosin and actin as promising saliva biomarkers for distinguishing pre-malignant and malignant oral lesions. PloS one, 2010 Jun 17; 5(6): e11148.
  • 12. Jou YJ, Lin CD, Lai CH, Chen CH, Kao JY, Chen SY, Tsai MH, Huang SH, Lin CW. Proteomic identification of salivary transferrin as a biomarker for early detection of oral cancer. Analytica chimica acta, 2010 Nov 29; 681(1-2): 41-8.
  • 13. Zhong LP, Chen GF, Xu ZF, Zhang X, Ping FY, Zhao SF. Detection of telomerase activity in saliva from oral squamous cell carcinoma patients. International journal of oral and maxillofacial surgery, 2005 Jul 1; 34(5): 566-70.
  • 14. Hu, S.; Arellano, M.; Boontheung, P.; Wang, J.; Zhou, H.; Jiang, J.; Elashoff, D.; Wei, R.; Loo, J.A.; Wong, D.T. Salivary proteomics for oral cancer biomarker discovery. Clin. Cancer Res., 2008; 14: 6246–6252.
  • 15. Hegde ND, Hegde MN, Priya G., An Insight on salivary biomarkers for oral Cancer. J Dent Craniofac Res. 2018; 3(2).
  • 16. El-Naggar AK, Mao L, Staerkel G, Coombes MM, Tucker SL, Luna MA, Clayman GL, Lippman S, Goepfert H. Genetic heterogeneity in saliva from patients with oral squamous carcinomas: implications in molecular diagnosis and screening. The Journal of Molecular Diagnostics, 2001 Nov 1; 3(4): 164-70.
  • 17. Jiang WW, Masayesva B, Zahurak M, Carvalho AL, Rosenbaum E, Mambo E, Zhou S, Minhas K, Benoit N, Westra WH, Alberg A. Increased mitochondrial DNA content in saliva associated with head and neck cancer. Clinical Cancer Research, 2005 Apr 1; 11(7): 2486-91.
  • 18. Liao PH, Chang YC, Huang MF, Tai KW, Chou MY. Mutation of p53 gene codon 63 in saliva as a molecular marker for oral squamous cell carcinomas. Oral oncology, 2000 May 1; 36(3): 272-6.
  • 19. Bettegowda, C.; Sausen, M.; Leary, R.J.; Kinde, I.; Wang, Y.; Agrawal, N.; Bartlett, B.R.; Wang, H.; Luber, B.; Alani, R.M.; et al. Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci. Transl. Med, 2014; 6: 224ra24.
  • 20. Wang, Y.; Springer, S.; Mulvey, C.L.; Silliman, N.; Schaefer, J.; Sausen, M.; James, N.; Rettig, E.M.; Guo, T.; Pickering, C.R.; et al. Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas. Sci. Transl. Med, 2015; 7: 293ra104.
  • 21. Hegde ND, Hegde MN, Priya G. An Insight on salivary biomarkers for oral Cancer. J Dent Craniofac Res, 2018; 3(2): 8.
  • 22. Yap, T.; Koo, K.; Cheng, L.; Vella, L.J.; Hill, A.F.; Reynolds, E.; Nastri, A.; Cirillo, N.; Seers, C.; McCullough, M. Predicting the presence of oral squamous cell carcinoma using commonly dysregulated MicroRNA in oral swirls. Cancer Prev. Res., 2018; 11: 491–502.
  • 23. Tang H, Wu Z, Zhang J, Su B: Salivary lncRNA as a potential marker for oral squamous cell carcinoma diagnosis. Mol Med Rep, 2013; 7(3): 761–6.
  • 24. Wei J, Xie G, Zhou Z, Shi P, Qiu Y, Zheng X, Chen T, Su M, Zhao A, Jia W. Salivary metabolite signatures of oral cancer and leukoplakia. International journal of cancer, 2011 Nov 1; 129(9): 2207-17.
  • 25. Ishikawa, S.; Sugimoto, M.; Kitabatake, K.; Sugano, A.; Nakamura, M.; Kaneko, M.; Ota, S.; Hiwatari, K.; Enomoto, A.; Soga, T.;et al. Identification of salivary metabolomic biomarkers for oral cancer screening. Sci. Rep., 2016; 6: 31520.
  • 26. Bernabé DG, Tamae AC, Miyahara GI, Sundefeld ML, Oliveira SP, Biasoli ÉR. Increased plasma and salivary cortisol levels in patients with oral cancer and their association with clinical stage. Journal of clinical pathology, 2012 Oct 1; 65(10): 934-9.
  • 27. Ma N, Tagawa T, Hiraku Y, Murata M, Ding X, Kawanishi S. 8-Nitroguanine formation in oral leukoplakia, a premalignant lesion. Nitric oxide, 2006 Mar 1; 14(2): 137-43.
  • 28. Chattopadhyay I, Verma M, Panda M. Role of oral microbiome signatures in diagnosis and prognosis of oral cancer. Technology in cancer research & treatment, 2019 Aug 1; 18: 1533033819867354.
  • 29. Liu S, Wang S, Zhang N, Li P. The oral microbiome and oral and upper gastrointestinal diseases. Journal of Oral Microbiology, 2024 Dec 31; 16(1): 2355823.
  • 30. Paster BJ, Boches SK, Galvin JL, Ericson RE, Lau CN, Levanos VA, Sahasrabudhe A, Dewhirst FE. Bacterial diversity in human subgingival plaque. Journal of bacteriology, 2001 Jun 15; 183(12): 3770-83.
  • 31. Li S, Tollefsbol TO. DNA methylation methods: Global DNA methylation and methylomic analyses. Methods, 2021 Mar 1; 187: 28-43.
  • 32. Lim Y, Wan Y, Vagenas D, Ovchinnikov DA, Perry CF, Davis MJ, Punyadeera C. Salivary DNA methylation panel to diagnose HPV-positive and HPV-negative head and neck cancers. BMC cancer, 2016 Dec; 16(1): 1-2.
  • 33. Liyanage C, Wathupola A, Muraleetharan S, Perera K, Punyadeera C, Udagama P. Promoter hypermethylation of tumor-suppressor genes p16INK4a, RASSF1A, TIMP3, and PCQAP/MED15 in salivary DNA as a quadruple biomarker panel for early detection of oral and oropharyngeal cancers. Biomolecules, 2019 Apr; 9(4): 148.
  • 34. Dongiovanni P, Meroni M, Casati S, Goldoni R, Thomaz DV, Kehr NS, Galimberti D, Del Fabbro M, Tartaglia GM. Salivary biomarkers: novel noninvasive tools to diagnose chronic inflammation. International journal of oral science, 2023 Jun 29; 15(1): 27.
  • 35. Starska-Kowarska K. Salivaomic Biomarkers—An Innovative Approach to the Diagnosis, Treatment, and Prognosis of Oral Cancer. Biology, 2025 Jul; 14(7): 852.
  • 36. Ghalwash DM. Diagnostic and prognostic value of salivary biomarkers in oral cancer and precancer. Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology, 2020 Nov 1; 32(6): 538-43.